Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 77,545 | 67,993 | 25,218 | 54,017 | 152,345 |
| Marketable Securities | 541,771 | 599,032 | 708,737 | 867,063 | 847,720 |
| Receivables | 10,006 | 30,220 | 22,492 | 28,994 | 28,871 |
| Inventories | 16,969 | 15,379 | 15,801 | 15,330 | 14,616 |
| Other current assets | 19,245 | 20,831 | 23,333 | 20,731 | 12,596 |
| TOTAL | $665,536 | $733,455 | $795,581 | $986,135 | $1,056,148 |
| Non-Current Assets | |||||
| PPE Net | 39,792 | 60,980 | 60,510 | 58,830 | 58,599 |
| Investments And Advances | 8,928 | 37,363 | 64,828 | 34,219 | 57,397 |
| Intangibles | 76,501 | 76,501 | 76,501 | 76,501 | 76,501 |
| Other Non-Current Assets | 71,230 | 115,817 | 119,769 | 121,558 | 122,706 |
| TOTAL | $196,451 | $290,661 | $321,608 | $291,108 | $315,203 |
| Total Assets | $861,987 | $1,024,116 | $1,117,189 | $1,277,243 | $1,371,351 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,346 | 12,617 | 9,747 | 23,660 | 19,701 |
| Accrued Expenses | 59,557 | 56,056 | 42,544 | 78,603 | 78,142 |
| TOTAL | $104,985 | $105,281 | $85,200 | $139,969 | $131,023 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 298,270 | 310,946 | 352,481 | 335,734 | 335,353 |
| TOTAL | $298,270 | $310,946 | $352,481 | $335,734 | $335,353 |
| Total Liabilities | $403,255 | $416,227 | $437,681 | $475,703 | $466,376 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,500 | 12,424 | 12,424 | 12,310 | 12,260 |
| Common Shares | 19 | 19 | 19 | 18 | 18 |
| Retained earnings | -3,082,456 | -2,923,388 | -2,832,995 | -2,687,350 | -2,557,644 |
| Other shareholders' equity | -8,191 | -6,532 | -4,157 | -3,563 | -3,400 |
| TOTAL | $458,732 | $607,889 | $679,508 | $801,540 | $904,975 |
| Total Liabilities And Equity | $861,987 | $1,024,116 | $1,117,189 | $1,277,243 | $1,371,351 |